Pages that link to "Q34231837"

The following pages link to Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor (Q34231837):

Displaying 50 items.

• Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies (Q26745527) ‎ (← links)
• How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? (Q26748867) ‎ (← links)
• Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues (Q26750671) ‎ (← links)
• Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health (Q27025003) ‎ (← links)
• Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments (Q28067102) ‎ (← links)
• Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies (Q33777096) ‎ (← links)
• Maternal-fetal cellular trafficking: clinical implications and consequences (Q33838736) ‎ (← links)
• Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies (Q33856960) ‎ (← links)
• Naturally acquired microchimerism (Q33921152) ‎ (← links)
• Haploidentical transplantation: the search for the best donor (Q34019548) ‎ (← links)
• Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection (Q34352679) ‎ (← links)
• KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. (Q34398420) ‎ (← links)
• Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation (Q34558107) ‎ (← links)
• The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. (Q35041195) ‎ (← links)
• Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission (Q35181654) ‎ (← links)
• MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells (Q35201839) ‎ (← links)
• Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation (Q35786957) ‎ (← links)
• Microchimerism in cord blood: mother as anticancer drug (Q35787149) ‎ (← links)
• HLA-targeted cell sorting of microchimeric cells opens the way to phenotypical and functional characterization (Q35877017) ‎ (← links)
• Alterations in maternal-fetal cellular trafficking after fetal surgery (Q36041489) ‎ (← links)
• Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members (Q36109429) ‎ (← links)
• Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance (Q36235327) ‎ (← links)
• Increased maternal microchimerism after open fetal surgery (Q36535733) ‎ (← links)
• Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application (Q36605814) ‎ (← links)
• Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications (Q36746512) ‎ (← links)
• Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning (Q36902123) ‎ (← links)
• Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting (Q37271276) ‎ (← links)
• Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation (Q37323408) ‎ (← links)
• Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation (Q37396289) ‎ (← links)
• Mother and child T cell receptor repertoires: deep profiling study. (Q37413084) ‎ (← links)
• Overview of the progress on haploidentical hematopoietic transplantation (Q37522577) ‎ (← links)
• Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses (Q37524719) ‎ (← links)
• Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias (Q37576040) ‎ (← links)
• Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer. (Q37590606) ‎ (← links)
• A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies (Q37694704) ‎ (← links)
• The great debate: haploidentical or cord blood transplant (Q37806066) ‎ (← links)
• Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation (Q37906064) ‎ (← links)
• At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies (Q38149725) ‎ (← links)
• Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers (Q38190856) ‎ (← links)
• Human NK cells: from surface receptors to the therapy of leukemias and solid tumors (Q38196803) ‎ (← links)
• Experts' considerations on HLA-haploidentical stem cell transplantation (Q38198728) ‎ (← links)
• Haploidentical stem cell transplantation for the treatment of leukemia: current status (Q38248521) ‎ (← links)
• Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias. (Q38569646) ‎ (← links)
• Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency (Q38904894) ‎ (← links)
• T cell depleted haploidentical transplantation: positive selection. (Q38912466) ‎ (← links)
• BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation (Q38922475) ‎ (← links)
• Can we make a better match or mismatch with KIR genotyping? (Q39027714) ‎ (← links)
• Markers and function of human NK cells in normal and pathological conditions (Q39068084) ‎ (← links)
• Minor histocompatibility antigen UTY as target for graft-versus-leukemia and graft-versus-haematopoiesis in the canine model (Q39249452) ‎ (← links)
• TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients. (Q39305147) ‎ (← links)